New Delhi: The Drug Controller General of India (DCGI) is likely to allow the emergency use of the Covishield vaccine in India without the necessary approval from the UK where it was developed, according to two senior government officials in the know of the matter.
If the clinical data furnished by the Serum Institute is found satisfactory, the DCGI may clear the shot for use, the officials said on the condition of anonymity.
“Serum Institute has submitted the additional data as sought by the subject expert committee in the last review (on 9 December),” one of the officials was quoted as saying by Mint
.Covishield — Serum Institute’s version of the vaccine — is being developed by Oxford University and British drugmaker AstraZeneca Plc. The expert panel had asked the Serum Institute in the December meeting to present the result of the assessment of the UK regulator for granting emergency use licence.
Bhubaneswar: As the flood situation in Odisha remained grim amid inundation of many areas, the…
Bhubaneswar: The Odisha University of Health Sciences (OUHS) on Thursday signed a number of memoranda…
New Delhi: The Supreme Court has refused to entertain a petition seeking direction about lawyers…
Bhubaneswar: The Shree Jagannath Temple Administration (SJTA) has urged the Archaeological Survey of India (ASI)…
New Delhi: The prospect of an all-out war with Iran intensified as Israel launched a major…
Bhubaneswar: As Bharatiya Janata Party (BJP) completed 100 days after coming to power in Odisha,…
Mumbai: Remember Vijayta Pandit? Yes, the younger sister of Sulakshana Pandit who burst into Bollywood…
Bhubaneswar: As the alleged custodial assault of an Army officer and his fiancée at Bharatpur…